77 related articles for article (PubMed ID: 8731825)
1. [The clonal origin of multiple myeloma].
Wang Y; Wu S; Xue H
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):663-5. PubMed ID: 8731825
[TBL] [Abstract][Full Text] [Related]
2. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.
Luque R; Brieva JA; Moreno A; Manzanal A; Escribano L; Villarrubia J; Velasco JL; López-Jiménez J; Cerveró C; Otero MJ; Martínez J; Bellas C; Roldán E
Clin Exp Immunol; 1998 Jun; 112(3):410-8. PubMed ID: 9649209
[TBL] [Abstract][Full Text] [Related]
3. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Jensen GS; Mant MJ; Belch AJ; Berenson JR; Ruether BA; Pilarski LM
Blood; 1991 Aug; 78(3):711-9. PubMed ID: 1830500
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
Pilarski LM; Jensen GS
Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
6. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
7. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.
Rawstron AC; Davies FE; Owen RG; English A; Pratt G; Child JA; Jack AS; Morgan GJ
Br J Haematol; 1998 Jan; 100(1):176-83. PubMed ID: 9450807
[TBL] [Abstract][Full Text] [Related]
8. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
9. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
10. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
12. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
[TBL] [Abstract][Full Text] [Related]
13. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).
Menke DM; Horny HP; Griesser H; Atkinson EJ; Kaiserling E; Kyle RA
J Clin Pathol; 1998 Jun; 51(6):432-7. PubMed ID: 9771441
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
Steen R; Tjønnfjord GE; Egeland T
J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
[TBL] [Abstract][Full Text] [Related]
16. Identification of early plasma cells in peripheral blood and their clinical significance.
Harada Y; Kawano MM; Huang N; Mahmoud MS; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1996 Jan; 92(1):184-91. PubMed ID: 8562394
[TBL] [Abstract][Full Text] [Related]
17. [Immunophenotypic characteristics of multiple myeloma cells].
Li JL; Liu YR; Chang Y; Fu JY; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):226-8. PubMed ID: 12513791
[TBL] [Abstract][Full Text] [Related]
18. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.
Pojero F; Flores-Montero J; Sanoja L; Pérez JJ; Puig N; Paiva B; Bottcher S; van Dongen JJ; Orfao A;
Cytometry B Clin Cytom; 2016 Jan; 90(1):91-100. PubMed ID: 26130131
[TBL] [Abstract][Full Text] [Related]
19. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation.
Koehne G; Zeller W; Stockschlaeder M; Zander AR
Bone Marrow Transplant; 1997 Jan; 19(2):149-56. PubMed ID: 9116612
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
